奥马珠单抗成功治疗线性IgA/IgG大疱性皮肤病：一例报告
Linear IgA/IgG bullous dermatosis successfully treated with omalizumab: A case report.
作者信息
Haulrig Morten Bahrt, Nielsen Signe Ledou, Elberling Jesper, Skov Lone
机构信息
Department of Dermatology and Allergy Herlev and Gentofte Hospital University of Copenhagen Hellerup Denmark.
Department of Pathology, Herlev and Gentofte Hospital University of Copenhagen Herlev Denmark.
出版信息
Clin Case Rep. 2022 Mar 8;10(3):e05368. doi: 10.1002/ccr3.5368. eCollection 2022 Mar.
Linear IgA/IgG bullous dermatosis (LAGBD) is a rare, autoimmune blistering skin disease. We report a case of LAGBD in a 70-year-old woman. All common treatments were discontinued due to side effects or lack of treatment response. The patient was successfully treated with omalizumab which cleared her lesions after three months.
线状IgA/IgG大疱性皮肤病（LAGBD）是一种罕见的自身免疫性水疱性皮肤病。我们报告一例70岁女性的LAGBD病例。由于副作用或缺乏治疗反应，所有常用治疗均已停用。该患者使用奥马珠单抗成功治疗，三个月后皮疹消退。
Zotero 插件